Cardiovascular Function in Acute Leukemia
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Cardiotoxicity
Related studies linked through entity extraction aliases.
Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
- Status
- RECRUITING
- Phase
- NA
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity
- Status
- UNKNOWN
- Phase
- NA
MyoStrain CMR for the Detection of Cardiotoxicity
- Status
- COMPLETED
- Phase
- N/A
Prevention of Chest Pain in Chemo-treated Cancer Patients
- Status
- COMPLETED
- Phase
- NA
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Status
- RECRUITING
- Phase
- PHASE3
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
The CAROLE (CArdiac Related Oncologic Late Effects) Study
- Status
- COMPLETED
- Phase
- N/A
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study
- Status
- UNKNOWN
- Phase
- PHASE2
Remote Ischaemic Preconditioning in Childhood Cancer
- Status
- COMPLETED
- Phase
- NA
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
- Status
- UNKNOWN
- Phase
- N/A
Early Detection of Cardiac Toxicity in Childhood Cancer Survivors
- Status
- TERMINATED
- Phase
- N/A
The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
- Status
- COMPLETED
- Phase
- PHASE2
Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
- Status
- COMPLETED
- Phase
- N/A
STOP Heart Disease in Breast Cancer Survivors Trial
- Status
- TERMINATED
- Phase
- PHASE2
The Cardio-Oncology Breast Cancer Study
- Status
- UNKNOWN
- Phase
- NA
Effect of Remote Ischaemic Conditioning in Oncology Patients
- Status
- UNKNOWN
- Phase
- NA
Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab
- Status
- UNKNOWN
- Phase
- PHASE3